1. Home
  2. NVEE vs KYMR Comparison

NVEE vs KYMR Comparison

Compare NVEE & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVEE
  • KYMR
  • Stock Information
  • Founded
  • NVEE 1949
  • KYMR 2015
  • Country
  • NVEE United States
  • KYMR United States
  • Employees
  • NVEE N/A
  • KYMR N/A
  • Industry
  • NVEE Other Consumer Services
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • NVEE Consumer Discretionary
  • KYMR Health Care
  • Exchange
  • NVEE Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • NVEE 1.5B
  • KYMR 1.8B
  • IPO Year
  • NVEE 2013
  • KYMR 2020
  • Fundamental
  • Price
  • NVEE $22.95
  • KYMR $44.35
  • Analyst Decision
  • NVEE Buy
  • KYMR Strong Buy
  • Analyst Count
  • NVEE 4
  • KYMR 16
  • Target Price
  • NVEE $25.67
  • KYMR $58.94
  • AVG Volume (30 Days)
  • NVEE 864.7K
  • KYMR 1.1M
  • Earning Date
  • NVEE 08-06-2025
  • KYMR 08-06-2025
  • Dividend Yield
  • NVEE N/A
  • KYMR N/A
  • EPS Growth
  • NVEE N/A
  • KYMR N/A
  • EPS
  • NVEE 0.45
  • KYMR N/A
  • Revenue
  • NVEE $962,752,000.00
  • KYMR $58,885,000.00
  • Revenue This Year
  • NVEE $11.23
  • KYMR $43.38
  • Revenue Next Year
  • NVEE $5.16
  • KYMR $10.97
  • P/E Ratio
  • NVEE $51.30
  • KYMR N/A
  • Revenue Growth
  • NVEE 8.74
  • KYMR N/A
  • 52 Week Low
  • NVEE $14.75
  • KYMR $19.45
  • 52 Week High
  • NVEE $26.14
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • NVEE 67.02
  • KYMR 56.46
  • Support Level
  • NVEE $22.47
  • KYMR $43.51
  • Resistance Level
  • NVEE $23.36
  • KYMR $46.67
  • Average True Range (ATR)
  • NVEE 0.31
  • KYMR 1.87
  • MACD
  • NVEE -0.10
  • KYMR -0.88
  • Stochastic Oscillator
  • NVEE 71.84
  • KYMR 10.06

About NVEE NV5 Global Inc.

NV5 Global Inc is a provider of technology, conformity assessment, and consulting solutions to public and private sector clients in the infrastructure, utility services, construction, real estate, environmental, and geospatial markets, operating nationwide and abroad. The Company's clients include the U.S. Federal, state and local governments, and the private sector. It also serve quasi-public and private sector clients from the education, healthcare, utility services, and public utilities, including schools, universities, hospitals, health care providers, and insurance providers. The operating business segments are Infrastructure, Building, Technology & Sciences, and Geospatial Solutions. The maximum revenue derives from the infrastructure segment.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: